Page 2 - U.K. (FTSE) Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 21, 2024

Discover U.K. Pharmaceuticals & Biotech Growth Stocks that are on the FTSE. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

70 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

FARN

Faron Pharmaceuticals Oy
UK£1.18-6.0%-63.2%UK£84.6mUK£9.94PE-3.2xE-1.0%n/a

ANCR

Animalcare Group
UK£2.17-1.4%17.3%UK£130.4mUK£2.94PE108.8xE-5.6%2.3%

MXCT

MaxCyte
UK£3.13-0.6%-22.7%UK£326.8mUK£7.61PS9.8xE-6.2%n/a

DEST

Destiny Pharma
UK£0.2121.4%-40.6%UK£20.3mUK£2.08PS20.5xE-11.0%n/a

4BB

4basebio
UK£10.351.5%58.0%UK£132.5mUK£12.00PS374.4xE-11.2%n/a

HVO

hVIVO
UK£0.27-5.5%57.1%UK£181.7mn/aPE11.3xE-12.1%0.7%

SCLP

Scancell Holdings
UK£0.096-2.5%-40.9%UK£78.7mn/aPE-8.3xE-13.4%n/a

POLB

Poolbeg Pharma
UK£0.116.5%41.3%UK£53.0mn/aPB3.2xE-13.8%n/a

REDX

Redx Pharma
UK£0.1233.3%-61.9%UK£46.7mUK£1.30PS11.1xE-22.3%n/a

C4XD

C4X Discovery Holdings
UK£0.082-3.5%-46.0%UK£20.7mn/aPE2xE-102.6%n/a

RENE

ReNeuron Group
UK£0.0340%-61.4%UK£1.9mn/aPS7.7xn/an/a

IXI

IXICO
UK£0.0870%-57.3%UK£4.2mn/aPB0.4xn/an/a

VRCI

Verici Dx
UK£0.080%-40.7%UK£19.4mn/aPS1263.5xS100.8%n/a

DVRG

DeepVerge
UK£0.00150%-92.2%UK£1.1mn/aPB0.05xn/an/a

APTA

Aptamer Group
UK£0.00554.8%-97.8%UK£2.6mn/aPS2.5xn/an/a

ROQ

Roquefort Therapeutics
UK£0.0484.4%-30.9%UK£6.1mn/aPS30.7xn/an/a

BSFA

BSF Enterprise
UK£0.05-4.8%-68.8%UK£5.2mn/aPS399.2xn/an/a

EVG

Evgen Pharma
UK£0.00770%-79.3%UK£3.3mn/aPS4xn/an/a

SNG

Synairgen
UK£0.0681.4%-41.5%UK£13.6mn/aPB0.9xn/an/a

CEL

Celadon Pharmaceuticals
UK£1.1521.1%-28.1%UK£73.8mUK£2.35PS3516.2xn/an/a

KNB

Kanabo Group
UK£0.017-7.5%-39.5%UK£10.5mn/aPS13xn/an/a

GENF

Genflow Biosciences
UK£0.015-4.6%-62.2%UK£5.4mn/aPS27.9xn/an/a

HEMO

Hemogenyx Pharmaceuticals
UK£0.0162.6%-16.9%UK£22.0mn/aPB6xn/an/a

IMM

ImmuPharma
UK£0.024-5.6%-17.7%UK£9.8mn/aPS139.9xn/an/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.